Epoxide Hydrolase Inhibitors [MoA] - N0000192345

Pharmacologic Class Information

Pharmacologic Code N0000192345
Pharmacologic Name Epoxide Hydrolase Inhibitors
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Epoxide Hydrolase Inhibitors

The following table contains 7 products whose active ingredient are classified under the same pharmacologic class Epoxide Hydrolase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50474-370Briviact Non-Proprietary Name: BrivaracetamTablet, Film CoatedOralUcb, Inc.ACTIVE
50474-470Briviact Non-Proprietary Name: BrivaracetamTablet, Film CoatedOralUcb, Inc.ACTIVE
50474-570Briviact Non-Proprietary Name: BrivaracetamTablet, Film CoatedOralUcb, Inc.ACTIVE
50474-670Briviact Non-Proprietary Name: BrivaracetamTablet, Film CoatedOralUcb, Inc.ACTIVE
50474-770Briviact Non-Proprietary Name: BrivaracetamTablet, Film CoatedOralUcb, Inc.ACTIVE
50474-870Briviact Non-Proprietary Name: BrivaracetamSolutionOralUcb, Inc.ACTIVE
50474-970Briviact Non-Proprietary Name: BrivaracetamInjection, SuspensionIntravenousUcb, Inc.ACTIVE